QMUL reject PACE FOI request from Ron Davis and colleagues

Queen Mary University of London (QMUL), acting on behalf of the authors of the highly controversial PACE trial, has rejected a request made by a group of scientists for raw, anonymised data from the trial.
The group was led by world-famous geneticist Professor Ron Davis of Stanford University, whose son, Whitney Dafoe, is gravely ill with ME/CFS. Professor Davis was joined in his request by biostatistician Professor Bruce Levin and immunologist Professor Vincent Racaniello, both of Columbia University, and Dr. David Tuller, Lecturer in Public Health and Journalism at the University of  California, Berkeley.
The scientists had requested data that would allow them to conduct analyses that the PACE authors had themselves specified in the original study protocol but abandoned. The analyses were replaced by others with “thresholds on the primary outcomes that indicated worse health than the study’s own entry criteria.” The analyses have been widely criticised and are the subject of an 11,000-strong petition asking the journals that published them to retract them.
Professor Davis and his colleagues made the request under the Freedom of Infomation Act, and QMUL waited the maximum allowable 20 working days before responding. Professor Racaniello, publishing the rejection letter on his Virology Blog, quipped, “At least we’re not vexatious,” in an apparent reference to QMUL’s history of dismissing PACE data requests on those grounds. The rejection was, said Dr Tuller, “as we expected.”
The letter claims that the data are exempt from disclosure because patients in the trial were guaranteed confidentiality and because the data “form part of an ongoing programme of research”. But, QMUL noted, “the PACE PIs and their associated organisations are currently reviewing a data sharing policy.”
Professor Davis and his group have 40 working days to appeal the decision. Meanwhile, Professor James Coyne has said that PLOS One’s lawyers and the PACE authors’ lawyers are “squaring off” over his own request for data relating to a PACE paper published in the journal, and an Information Rights Tribunal is due to soon hear the case of a patient who was refused PACE data by QMUL.

Facebook
Twitter
WhatsApp
Email

Latest News

black square image with two white lines at the top and bottom of the image. Then another two white lines come out from the sides to the middle over the #MEAction logo and the words, #NotJustFatigue Video Series Elizabeth Ansell Interview.

#NotJustFatigue Video Series: Interview with Creator Elizabeth Ansell

Over the past year, the #NotJustFatigue website, created by Elizabeth Ansell, releases a 10-part, documentary style, short form video series on different aspects involved in living with ME. Titles of the videos include topics such as: You Have No Idea How Serious This Is, Nobody Believes ME, and It’s Not Hysteria: It’s Sexism. In these

Read More »
navy blue square. there are two white lines at the top and bottom of the square. The #MEAction logo in at the top of the image. The words #MEAction Georgia Voice of the Patient in coordination with the Center for Disease Control and Prevention & Emory School of Nursing.

#MEAction Georgia: Voice of the Patient in Coordination with CDC & Emory School on Nursing

Back in September, #MEAction Georgia State Chapter partnered with the Centers for Disease Control and Prevention (CDC) and Emory School of Nursing to host, Voice of the Patient: A Panel Discussion with #MEAction Georgia. This event was a continuation of #MEAction Georgia’s #MillionsMissing 2024: #TeachMETreatME programming. Erin Lee and Liz Burlingame of the #MEAction Georgia

Read More »
a light blue square image with medical instruments/tools as a border (pill bottles, scales, needles, covid protein spike, etc). At the top of the image is the Home Test to Treat Program logo, in blue font: Findings Summary. Below that the #MEAction logo and Body Politic Logo.

Home Test To Treat – Findings Summary

#MEAction and Body Politic collaborated last spring, with a new national telehealth program, Home Test to Treat. We are now able to share initial findings from the program! Here are some highlights: 80K + enrolled in the program across the country! 40K + test distributed 6K + individuals treated for COVID-19 or flu 5.6K+ organizations

Read More »
Scroll to Top